Evidence map›Paper›PMID 36098245›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Efficient Copper-Catalyzed Highly Stereoselective Synthesis of Unprotected C-Acyl Manno-, Rhamno- and Lyxopyranosides.

Gordon Jacob Boehlich, Hannes Sterzel, Julia Rehbein, Nina Schützenmeister

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Synthesis of Aryl-β-C-Glycosides from Native Saccharides.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gordon Jacob BoehlichFakultät für Chemie und Pharmazie, Universität Hamburg, Bundesstraße 45, 20146, Hamburg, Germany.
Hannes SterzelFachbereich Chemie, Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.
Julia RehbeinFachbereich Chemie, Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.ORCID http://orcid.org/0000-0001-9241-0637
Nina SchützenmeisterDepartment of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0001-9608-0057

Funding

Deutsche Forschungsgemeinschaft RE3630/5-1Universität Hamburg Hamburg StipendiumVerband der Chemischen Industrie
6 · The paper itself

Abstract

Due to their high stability towards enzymatic hydrolysis C-acyl glycosidic compounds are useful synthetic intermediates for potential candidates in drug discovery. Syntheses for C-acyl mannosides have remained scarce and usually employ donors obtained from lengthy syntheses. Furthermore, syntheses of unprotected C-acyl mannosides have not been reported so far, due to the incapability of the C-acyl mannoside motif with deprotection conditions for protective groups commonly used in carbohydrate chemistry. Herein, we report an efficient and highly α-selective four-step one-pot method for the synthesis of C-acyl α-d-manno-, l-rhamno- and d-lyxopyranosides from easily accessible persilylated monosaccharides and dithianes requiring only trace amounts of a copper source as catalyst and explain the crucial role of the catalyst by mechanistic studies. Furthermore, the C-acyl α-glycosides were easily isomerized to give rapid access to their β-anomers.

Indexed as

CopperMannosidesCatalysisGlycosylationStereoisomerismCopperMannosidescarbohydratesC-glycosylationcopper catalysiscorey-seebach reactionreaction mechanism

Identifiers

PMID36098245
PMCPMC10091970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.